NOVO.B.DK

265.75

+0.78%↑

GMAB.DK

1,693.5

-0.88%↓

HLUNB.DK

43.02

-1.96%↓

ZEAL.DK

308.4

+1.92%↑

AMBUB.DK

65

-0.08%↓

NOVO.B.DK

265.75

+0.78%↑

GMAB.DK

1,693.5

-0.88%↓

HLUNB.DK

43.02

-1.96%↓

ZEAL.DK

308.4

+1.92%↑

AMBUB.DK

65

-0.08%↓

NOVO.B.DK

265.75

+0.78%↑

GMAB.DK

1,693.5

-0.88%↓

HLUNB.DK

43.02

-1.96%↓

ZEAL.DK

308.4

+1.92%↑

AMBUB.DK

65

-0.08%↓

NOVO.B.DK

265.75

+0.78%↑

GMAB.DK

1,693.5

-0.88%↓

HLUNB.DK

43.02

-1.96%↓

ZEAL.DK

308.4

+1.92%↑

AMBUB.DK

65

-0.08%↓

NOVO.B.DK

265.75

+0.78%↑

GMAB.DK

1,693.5

-0.88%↓

HLUNB.DK

43.02

-1.96%↓

ZEAL.DK

308.4

+1.92%↑

AMBUB.DK

65

-0.08%↓

Search

Coloplast A-S (Class B)

Fechado

407.9 0.52

Visão Geral

Variação de preço das ações

24h

Atual

Mín

400.4

Máximo

409.8

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.492

60.328

EPS

6.32

Rendimento de Dividendos

5.28

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.28%

2.24%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-21B

98B

Abertura anterior

407.38

Fecho anterior

407.9

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de abr. de 2026, 23:15 UTC

Notícias Principais

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 de abr. de 2026, 23:08 UTC

Ganhos
Grandes Movimentos do Mercado

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 de abr. de 2026, 23:58 UTC

Ganhos

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 de abr. de 2026, 23:58 UTC

Ganhos

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 de abr. de 2026, 23:56 UTC

Ganhos

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 de abr. de 2026, 23:56 UTC

Ganhos

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 de abr. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 de abr. de 2026, 23:42 UTC

Conversa de Mercado

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 de abr. de 2026, 23:34 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 de abr. de 2026, 23:30 UTC

Conversa de Mercado

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 de abr. de 2026, 23:08 UTC

Conversa de Mercado

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 de abr. de 2026, 23:02 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de abr. de 2026, 23:02 UTC

Conversa de Mercado

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 de abr. de 2026, 22:42 UTC

Conversa de Mercado

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 de abr. de 2026, 22:10 UTC

Ganhos

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 de abr. de 2026, 22:09 UTC

Ganhos

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 de abr. de 2026, 22:09 UTC

Ganhos

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 de abr. de 2026, 22:09 UTC

Ganhos

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 de abr. de 2026, 21:56 UTC

Ganhos

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 de abr. de 2026, 21:55 UTC

Ganhos

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 de abr. de 2026, 21:55 UTC

Ganhos

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 de abr. de 2026, 21:44 UTC

Ganhos

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 de abr. de 2026, 21:43 UTC

Ganhos

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 de abr. de 2026, 21:41 UTC

Ganhos

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 de abr. de 2026, 21:41 UTC

Ganhos

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

27 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

27 de abr. de 2026, 20:39 UTC

Ganhos

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat